Aricept

Treatment of Alzheimer's Disease

Aricept is primarily prescribed to treat dementia associated with Alzheimer's disease. It is used for patients at various stages of the condition, including:

• Mild Alzheimer's disease
• Moderate Alzheimer's disease
• Severe Alzheimer's disease

Dementia is a brain disorder that impacts a person's ability to remember, think clearly, communicate, and perform daily tasks. It may also lead to changes in personality or mood.

How It Helps

While Aricept does not cure Alzheimer's disease or stop the underlying progression of the condition, it is used to help improve or maintain mental function. This includes:

• Memory and awareness
• The ability to perform daily activities
• Thinking and reasoning skills
• Communication abilities

The medication works by improving the function of nerve cells in the brain, which may help manage symptoms of confusion and memory loss for a period of time.

Mechanism of Action

Aricept works by preventing the breakdown of a natural substance in the brain called acetylcholine. Acetylcholine is a neurotransmitter, a type of chemical messenger that nerve cells use to communicate with one another. It plays a vital role in functions such as memory, learning, and thinking.

In people with Alzheimer's disease, the levels of acetylcholine in the brain are typically lower than normal. Aricept blocks the action of an enzyme called acetylcholinesterase, which is responsible for breaking down acetylcholine. By inhibiting this enzyme, the medication allows more acetylcholine to remain available for nerve cells to use.

Impact on Symptoms

By supporting communication between nerve cells, Aricept may help improve or stabilize symptoms related to:

• Memory and awareness
• The ability to perform daily tasks
• Thinking and reasoning skills

It is important to note that while Aricept can help manage the symptoms of dementia, it is not a cure for Alzheimer's disease. It does not stop the underlying progression of the disease or repair the nerve cells already damaged by the condition.

Common Side Effects

Many people using Aricept experience mild side effects, which often improve as the body adjusts to the medication. Common symptoms include:

• Nausea, vomiting, or diarrhea
• Loss of appetite and weight loss
• Muscle cramps
• Feeling tired or weak
• Difficulty sleeping (insomnia)
• Dizziness

Serious Side Effects

Contact a healthcare provider immediately if any of the following serious side effects occur:

• Fainting or feeling lightheaded
• Slow heartbeat
• New or worsening lung problems, such as asthma or chronic obstructive pulmonary disease (COPD)
• Seizures
• Difficulty urinating
• Severe stomach pain
• Signs of stomach bleeding, such as black, tarry stools or vomit that looks like coffee grounds

Rarely, some people may experience a severe skin reaction or an allergic reaction involving a rash, itching, or swelling of the face, tongue, or throat.

Heart and Circulation

Aricept can cause a slow heart rate (bradycardia) and fainting. These effects may occur in people with or without known heart rhythm disorders. Healthcare providers may monitor for signs of heart block or other cardiac conduction issues.

Gastrointestinal Risks

This medication increases the production of stomach acid, which can lead to gastrointestinal bleeding or ulcers. The risk is higher for individuals with a history of ulcers or those taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin. Common side effects like nausea, vomiting, and diarrhea are also frequent, particularly when starting the drug or increasing the dose.

Respiratory and Urinary Issues

Because of its effect on the nervous system, Aricept may worsen asthma or chronic obstructive pulmonary disease (COPD). It may also cause bladder outflow obstruction, making it difficult to pass urine.

Neurological and Muscle Reactions

While seizures can be a symptom of Alzheimer's disease, Aricept may also increase the risk of convulsions. In rare cases, serious conditions have been reported, including:

• Neuroleptic Malignant Syndrome (NMS): A potentially life-threatening reaction involving high fever, muscle stiffness, and altered mental status.
• Rhabdomyolysis: A rare condition where muscle tissue breaks down, potentially causing kidney damage. Symptoms include unexplained muscle pain, weakness, or dark-colored urine.

Anesthesia Interactions

Aricept may increase the effects of certain muscle relaxants used during general anesthesia. It is important for surgical teams to be aware if a patient is taking this medication before any procedure.

Contraindications

Aricept should not be used by individuals with a known hypersensitivity to donepezil hydrochloride or piperidine derivatives.

Pregnancy

It is not known whether Aricept (donepezil) can cause harm to an unborn baby. There are no adequate or well-controlled studies of this medication in pregnant women. Because Alzheimer's disease typically affects older individuals, the use of this drug in people of childbearing age is rare.

If you are pregnant or planning to become pregnant, discuss the potential risks and benefits with your healthcare provider. Aricept should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.

Breastfeeding

It is unknown if donepezil passes into human breast milk or if it could affect a nursing infant. Because many drugs are excreted in human milk, caution is advised. If you are breastfeeding, consult your doctor to determine the best course of action for your health and the safety of your baby.

Available Forms

Aricept is provided in the following oral formulations:

• Film-coated tablets: These tablets are intended to be swallowed whole with water.
• Orally disintegrating tablets (ODT): These tablets are designed to dissolve quickly on the tongue and can be taken with or without water.

FDA Approval and Indications

Aricept (donepezil) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of dementia of the Alzheimer's type. It is indicated for use in patients with mild, moderate, and severe stages of the disease.

Regulatory Status

Aricept is a prescription-only medication and is not a controlled substance. It does not currently carry any boxed warnings, which are the FDA's most serious warnings for medications. The drug is available in several forms, including oral tablets and orally disintegrating tablets (ODT).

Safety Monitoring and Communications

The FDA continuously monitors the safety profile of Aricept through the FDA Adverse Event Reporting System (FAERS). In 2023, the FDA identified a potential signal of a serious risk regarding pleural effusion (an accumulation of fluid around the lungs) associated with the use of donepezil. The agency is currently evaluating this data to determine if regulatory action, such as updating the product labeling, is required.

Approved Uses

The U.S. Food and Drug Administration (FDA) has approved Aricept (donepezil) for the treatment of dementia of the Alzheimer's type. It is specifically indicated for patients in the following stages of the disease:

• Mild Alzheimer's disease
• Moderate Alzheimer's disease
• Severe Alzheimer's disease

Approval Background

Aricept received its initial FDA approval in 1996. It was the first medication approved in the United States to treat symptoms across all stages of Alzheimer's disease, from mild to severe. The FDA has authorized several formulations of the drug, including oral tablets and orally disintegrating tablets.

Clinical Considerations

FDA approval was based on clinical studies demonstrating that the medication can improve cognitive function, such as memory and thinking, and the ability to perform daily tasks. However, the FDA labeling clarifies that Aricept is not a cure for Alzheimer's disease and does not alter the progression of the underlying neurological decline.